Selected research
Industry Growth & Trends
Global Iridoids Industry Growth and Trends Forecast to 2032
Market perspective
The global Iridoids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iridoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Iridoids include Wuhan Chengyuan Pharmaceutical Co, Shaanxi Sciphar Hi-Tech, Lunan Pharmaceutical Group, Kemin Industries, Sigma-Aldrich, Nexira, Martin Bauer Group, LKT Labs and Layn Natural Ingredients, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Iridoids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Iridoids market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Iridoids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Iridoids.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Iridoids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Iridoids Market by Company
Wuhan Chengyuan Pharmaceutical Co
Shaanxi Sciphar Hi-Tech
Lunan Pharmaceutical Group
Kemin Industries
Sigma-Aldrich
Nexira
Martin Bauer Group
LKT Labs
Layn Natural Ingredients
Indena
Enzo Life Sciences
Dalian Sky Chemical
Iridoids Segment by Type
Natural
Synthesis
Iridoids Segment by Application
Drugs
Health Products
Others
Iridoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iridoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iridoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iridoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iridoids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Iridoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural
- Synthesis
Applications
- Drugs
- Health Products
- Others
Companies covered
- Wuhan Chengyuan Pharmaceutical Co
- Shaanxi Sciphar Hi-Tech
- Lunan Pharmaceutical Group
- Kemin Industries
- Sigma-Aldrich
- Nexira
- Martin Bauer Group
- LKT Labs
- Layn Natural Ingredients
- Indena
- Enzo Life Sciences
- Dalian Sky Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Iridoids Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Iridoids Sales Estimates and Forecasts (2021-2032)
- 1.3 Iridoids Market by Type
- 1.3.1 Natural
- 1.3.2 Synthesis
- 1.4 Global Iridoids Market Size by Type
- 1.4.1 Global Iridoids Market Size Overview by Type (2021-2032)
- 1.4.2 Global Iridoids Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Iridoids Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Iridoids Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Iridoids Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Iridoids Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Iridoids Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Iridoids Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Iridoids Industry Trends
- 2.2 Iridoids Industry Drivers
- 2.3 Iridoids Industry Opportunities and Challenges
- 2.4 Iridoids Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Iridoids Revenue (2021-2026)
- 3.2 Global Top Players by Iridoids Sales (2021-2026)
- 3.3 Global Top Players by Iridoids Price (2021-2026)
- 3.4 Global Iridoids Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iridoids Major Company Production Sites & Headquarters
- 3.6 Global Iridoids Company, Product Type & Application
- 3.7 Global Iridoids Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Iridoids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Iridoids Players Market Share by Revenue in 2025
- 3.8.3 2025 Iridoids Tier 1, Tier 2, and Tier 3
4 Iridoids Regional Status and Outlook
- 4.1 Global Iridoids Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Iridoids Historic Market Size by Region
- 4.2.1 Global Iridoids Sales in Volume by Region (2021-2026)
- 4.2.2 Global Iridoids Sales in Value by Region (2021-2026)
- 4.2.3 Global Iridoids Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Iridoids Forecasted Market Size by Region
- 4.3.1 Global Iridoids Sales in Volume by Region (2027-2032)
- 4.3.2 Global Iridoids Sales in Value by Region (2027-2032)
- 4.3.3 Global Iridoids Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Iridoids by Application
- 5.1 Iridoids Market by Application
- 5.1.1 Drugs
- 5.1.2 Health Products
- 5.1.3 Others
- 5.2 Global Iridoids Market Size by Application
- 5.2.1 Global Iridoids Market Size Overview by Application (2021-2032)
- 5.2.2 Global Iridoids Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Iridoids Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Iridoids Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Iridoids Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Iridoids Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Iridoids Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Iridoids Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Wuhan Chengyuan Pharmaceutical Co
- 6.1.1 Wuhan Chengyuan Pharmaceutical Co Company Information
- 6.1.2 Wuhan Chengyuan Pharmaceutical Co Business Overview
- 6.1.3 Wuhan Chengyuan Pharmaceutical Co Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Wuhan Chengyuan Pharmaceutical Co Iridoids Product Portfolio
- 6.1.5 Wuhan Chengyuan Pharmaceutical Co Recent Developments
- 6.2 Shaanxi Sciphar Hi-Tech
- 6.2.1 Shaanxi Sciphar Hi-Tech Company Information
- 6.2.2 Shaanxi Sciphar Hi-Tech Business Overview
- 6.2.3 Shaanxi Sciphar Hi-Tech Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shaanxi Sciphar Hi-Tech Iridoids Product Portfolio
- 6.2.5 Shaanxi Sciphar Hi-Tech Recent Developments
- 6.3 Lunan Pharmaceutical Group
- 6.3.1 Lunan Pharmaceutical Group Company Information
- 6.3.2 Lunan Pharmaceutical Group Business Overview
- 6.3.3 Lunan Pharmaceutical Group Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Lunan Pharmaceutical Group Iridoids Product Portfolio
- 6.3.5 Lunan Pharmaceutical Group Recent Developments
- 6.4 Kemin Industries
- 6.4.1 Kemin Industries Company Information
- 6.4.2 Kemin Industries Business Overview
- 6.4.3 Kemin Industries Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Kemin Industries Iridoids Product Portfolio
- 6.4.5 Kemin Industries Recent Developments
- 6.5 Sigma-Aldrich
- 6.5.1 Sigma-Aldrich Company Information
- 6.5.2 Sigma-Aldrich Business Overview
- 6.5.3 Sigma-Aldrich Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sigma-Aldrich Iridoids Product Portfolio
- 6.5.5 Sigma-Aldrich Recent Developments
- 6.6 Nexira
- 6.6.1 Nexira Company Information
- 6.6.2 Nexira Business Overview
- 6.6.3 Nexira Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nexira Iridoids Product Portfolio
- 6.6.5 Nexira Recent Developments
- 6.7 Martin Bauer Group
- 6.7.1 Martin Bauer Group Company Information
- 6.7.2 Martin Bauer Group Business Overview
- 6.7.3 Martin Bauer Group Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Martin Bauer Group Iridoids Product Portfolio
- 6.7.5 Martin Bauer Group Recent Developments
- 6.8 LKT Labs
- 6.8.1 LKT Labs Company Information
- 6.8.2 LKT Labs Business Overview
- 6.8.3 LKT Labs Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 LKT Labs Iridoids Product Portfolio
- 6.8.5 LKT Labs Recent Developments
- 6.9 Layn Natural Ingredients
- 6.9.1 Layn Natural Ingredients Company Information
- 6.9.2 Layn Natural Ingredients Business Overview
- 6.9.3 Layn Natural Ingredients Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Layn Natural Ingredients Iridoids Product Portfolio
- 6.9.5 Layn Natural Ingredients Recent Developments
- 6.10 Indena
- 6.10.1 Indena Company Information
- 6.10.2 Indena Business Overview
- 6.10.3 Indena Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Indena Iridoids Product Portfolio
- 6.10.5 Indena Recent Developments
- 6.11 Enzo Life Sciences
- 6.11.1 Enzo Life Sciences Company Information
- 6.11.2 Enzo Life Sciences Business Overview
- 6.11.3 Enzo Life Sciences Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Enzo Life Sciences Iridoids Product Portfolio
- 6.11.5 Enzo Life Sciences Recent Developments
- 6.12 Dalian Sky Chemical
- 6.12.1 Dalian Sky Chemical Company Information
- 6.12.2 Dalian Sky Chemical Business Overview
- 6.12.3 Dalian Sky Chemical Iridoids Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Dalian Sky Chemical Iridoids Product Portfolio
- 6.12.5 Dalian Sky Chemical Recent Developments
7 North America by Country
- 7.1 North America Iridoids Sales by Country
- 7.1.1 North America Iridoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Iridoids Sales by Country (2021-2026)
- 7.1.3 North America Iridoids Sales Forecast by Country (2027-2032)
- 7.2 North America Iridoids Market Size by Country
- 7.2.1 North America Iridoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Iridoids Market Size by Country (2021-2026)
- 7.2.3 North America Iridoids Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Iridoids Sales by Country
- 8.1.1 Europe Iridoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Iridoids Sales by Country (2021-2026)
- 8.1.3 Europe Iridoids Sales Forecast by Country (2027-2032)
- 8.2 Europe Iridoids Market Size by Country
- 8.2.1 Europe Iridoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Iridoids Market Size by Country (2021-2026)
- 8.2.3 Europe Iridoids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Iridoids Sales by Country
- 9.1.1 Asia-Pacific Iridoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Iridoids Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Iridoids Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Iridoids Market Size by Country
- 9.2.1 Asia-Pacific Iridoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Iridoids Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Iridoids Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Iridoids Sales by Country
- 10.1.1 South America Iridoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Iridoids Sales by Country (2021-2026)
- 10.1.3 South America Iridoids Sales Forecast by Country (2027-2032)
- 10.2 South America Iridoids Market Size by Country
- 10.2.1 South America Iridoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Iridoids Market Size by Country (2021-2026)
- 10.2.3 South America Iridoids Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Iridoids Sales by Country
- 11.1.1 Middle East and Africa Iridoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Iridoids Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Iridoids Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Iridoids Market Size by Country
- 11.2.1 Middle East and Africa Iridoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Iridoids Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Iridoids Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Iridoids Value Chain Analysis
- 12.1.1 Iridoids Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Iridoids Production Mode & Process
- 12.2 Iridoids Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Iridoids Distributors
- 12.2.3 Iridoids Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst